Cargando…

Genetic features of precursor B‐cell phenotype Burkitt leukemia with IGH‐ MYC rearrangement

BACKGROUND: An atypical form of Burkitt leukemia/lymphoma (BL), BL with a phenotype of precursor B‐cells (preBLL), is listed in the WHO Classification. Recent reports suggested that preBLL and classical BL could be distinguished by the differences in IG‐MYC translocation architecture and an addition...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoshida, Masanori, Tomizawa, Daisuke, Yoshimura, Satoshi, Osumi, Tomoo, Nakabayashi, Kazuhiko, Ogata‐Kawata, Hiroko, Ishiwata, Keisuke, Sato‐Otsubo, Aiko, Kimura, Yui, Ito, Shuichi, Matsumoto, Kimikazu, Deguchi, Takao, Kiyokawa, Nobutaka, Yoshioka, Takako, Hata, Kenichiro, Kato, Motohiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327653/ https://www.ncbi.nlm.nih.gov/pubmed/34472720 http://dx.doi.org/10.1002/cnr2.1545

Ejemplares similares

Minimal residual disease detection by mutation-specific droplet digital PCR for leukemia/lymphoma
por: Shirai, Ryota, et al.
Publicado: (2023)

Prevalence of pathogenic variants in cancer‐predisposing genes in second cancer after childhood solid cancers
por: Yoshida, Masanori, et al.
Publicado: (2023)

Genetic features of B‐cell lymphoblastic lymphoma with TCF3‐PBX1
por: Shirai, Ryota, et al.
Publicado: (2021)

Enhancer RNA AL928768.3 from the IGH Locus Regulates MYC Expression and Controls the Proliferation and Chemoresistance of Burkitt Lymphoma Cells with IGH/MYC Translocation
por: Stasevich, Ekaterina Mikhailovna, et al.
Publicado: (2022)

Improvement of diagnosis in children with Burkitt lymphoma in Kenya: feasibility study for the implementation of fluorescence in situ hybridisation testing for MYC and the MYC/IGH translocation
por: Vance, Gail H, et al.
Publicado: (2023)

NUDT15 variants confer high incidence of second malignancies in children with acute lymphoblastic leukemia
por: Yoshida, Masanori, et al.
Publicado: (2021)

ATRT-11. PREVALENCE OF GERMLINE VARIANTS IN SMARCB1 INCLUDING SOMATIC MOSAICISM IN AT/RT AND OTHER RHABDOID TUMORS
por: Shirai, Ryota, et al.
Publicado: (2020)

Establishment of multiplex RT-PCR to detect fusion genes for the diagnosis of Ewing sarcoma
por: Ueno-Yokohata, Hitomi, et al.
Publicado: (2021)

Double-Hit Primary Plasma Cell Leukemia with IGH/MYC and IGH/CCND1 Translocations
por: Yasumi, Masato, et al.
Publicado: (2020)

HGG-49. A PEDIATRIC THALAMIC HIGH-GRADE GLIOMA WITH H3F3A K27M AND BRAF V600E DOUBLE MUTATIONS
por: Terashima, Keita, et al.
Publicado: (2020)

Long-range Oncogenic Activation of IgH/c-myc Translocations by the IgH 3’ Regulatory Region
por: Gostissa, Monica, et al.
Publicado: (2009)

Plasmablastic lymphoma with MYC::IGH fusion and BCL2 rearrangement
por: Barouqa, Mohammad, et al.
Publicado: (2022)

Successful hematopoietic stem cell transplantation with reduced dose of busulfan for Omenn syndrome
por: Matsukawa, Yukihiro, et al.
Publicado: (2022)

DNA Methylation Profile Distinguishes Clear Cell Sarcoma of the Kidney from Other Pediatric Renal Tumors
por: Ueno, Hitomi, et al.
Publicado: (2013)

Myc Dynamically and Preferentially Relocates to a Transcription Factory Occupied by Igh
por: Osborne, Cameron S, et al.
Publicado: (2007)

Nucleolar tethering mediates pairing between the IgH and Myc loci
por: Strongin, Daniel E, et al.
Publicado: (2014)

Role of monocyte chemoattractant protein‐1 in liver fibrosis with transient myeloproliferative disorder in down syndrome
por: Kobayashi, Kenichiro, et al.
Publicado: (2018)

Variations in gender identity and sexual orientation of university students
por: Yoshida, Tomoko, et al.
Publicado: (2023)

Burkitt lymphoma beyond MYC translocation: N-MYC and DNA methyltransferases dysregulation
por: De Falco, Giulia, et al.
Publicado: (2015)

The IgH 3′ regulatory region influences lymphomagenesis in Igλ-Myc mice
por: Saad, Faten, et al.
Publicado: (2015)

The IgH 3’ regulatory region and c-myc-induced B-cell lymphomagenesis
por: Ghazzaui, Nour, et al.
Publicado: (2016)

ETMR-11. A CASE OF PRIMARY DIFFUSE LEPTOMENINGEAL PRIMITIVE NEUROECTODERMAL TUMOR
por: Sugawa, Masahiro, et al.
Publicado: (2020)

PB1913: IGH 3’RR RECOMBINATION UNCOVERS A NON-GC IMPRINT AND C-MYC-DEPENDENT IGH REARRANGEMENT ACTIVITY IN UNMUTATED CHRONIC LYMPHOCYTIC LEUKEMIA
por: Jamal, Israa Al, et al.
Publicado: (2023)

A role for AID in chromosome translocations between c-myc and the IgH variable region
por: Dorsett, Yair, et al.
Publicado: (2007)

A role for AID in chromosome translocations between c-myc and the IgH variable region
por: Dorsett, Yair, et al.
Publicado: (2007)

Deep Sequencing of MYC DNA-Binding Sites in Burkitt Lymphoma
por: Seitz, Volkhard, et al.
Publicado: (2011)

Alteration of MicroRNAs Regulated by c-Myc in Burkitt Lymphoma
por: Onnis, Anna, et al.
Publicado: (2010)

Developments in Burkitt’s lymphoma: novel cooperations in oncogenic MYC signaling
por: Spender, Lindsay C, et al.
Publicado: (2014)

Elucidating a false-negative MYC break-apart fluorescence in situ hybridization probe study by next-generation sequencing in a patient with high-grade B-cell lymphoma with IGH/MYC and IGH/BCL2 rearrangements
por: Peterson, Jess F., et al.
Publicado: (2019)

Molecular switch from MYC to MYCN expression in MYC protein negative Burkitt lymphoma cases
por: Mundo, Lucia, et al.
Publicado: (2019)

A capture methyl-seq protocol with improved efficiency and cost-effectiveness using pre-pooling and enzymatic conversion
por: Hasegawa, Keita, et al.
Publicado: (2023)

IGH amplification in patients with B cell lymphoma unclassifiable, with features intermediate between diffuse large B cell lymphoma and Burkitt’s lymphoma
por: Bellone, Michael, et al.
Publicado: (2014)

Improved library preparation protocols for amplicon sequencing-based noninvasive fetal genotyping for RHD-positive D antigen-negative alleles
por: Hori, Asuka, et al.
Publicado: (2021)

Targeting the MYC Oncogene in Burkitt Lymphoma through HSP90 Inhibition
por: Poole, Candace J., et al.
Publicado: (2018)

Exploring trophoblast-specific Tead4 enhancers through chromatin conformation capture assays followed by functional screening
por: Tomikawa, Junko, et al.
Publicado: (2020)

CD5-negative Blastoid Variant Mantle Cell Lymphoma with Complex CCND1/IGH and MYC Aberrations
por: Seok, Yoonmi, et al.
Publicado: (2012)

Mouse Models of c-myc Deregulation Driven by IgH Locus Enhancers as Models of B-Cell Lymphomagenesis
por: Ferrad, Melissa, et al.
Publicado: (2020)

The 11q-Gain/Loss Aberration Occurs Recurrently in MYC-Negative Burkitt-like Lymphoma With 11q Aberration, as Well as MYC-Positive Burkitt Lymphoma and MYC-Positive High-Grade B-Cell Lymphoma, NOS
por: Grygalewicz, Beata, et al.
Publicado: (2018)

MYC chromosomal aberration in differential diagnosis between Burkitt and other aggressive lymphomas
por: Aquino, Gabriella, et al.
Publicado: (2013)

Tuberous sclerosis complex is required for tumor maintenance in MYC‐driven Burkitt's lymphoma
por: Hartleben, Götz, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dkohrl0qp2a2o0miurnmml86em